Afficher la couverture 'Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma. Efficacité des inhibiteurs de checkpoint immunitaire dans le carcinome sarcomatoïde du poumon : données issues d'une cohorte française multicentrique | Domblides, Charlotte' en grand format
/5

0 avis

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma. Efficacité des inhibiteurs de checkpoint immunitaire dans le carcinome sarcomatoïde du poumon : données issues d'une cohorte française multicentrique

Archive ouverte

Domblides, Charlotte | Leroy, Karen | Monnet, Isabelle | Mazières, Julien | Barlesi, Fabrice | Gounant, Valérie | Baldacci, Simon | Mennecier, Bertrand | Toffart, Anne-Claire | Audigier-Valette, Clarisse | Doucet, Ludovic | Giroux-Leprieur, Etienne | Guisier, Florian | Ricordel, Charles | Molinier, Olivier | Pérol, Maurice | Pichon, Eric | Robinet, Gilles | Templement-Grangerat, Dorine | Ruppert, Anne-Marie | Rabbe, Nathalie | Antoine, Martine | Wislez, Marie

Edité par CCSD -

National audience. Immune checkpoint inhibitors (ICIs) have improved cancer prognosis but have not been evaluated specifically in sarcomatoid carcinoma (SC), a rare lung cancer subtype with poor prognosis. As such, our study sought to retrospectively assess the efficacy of ICI in SC.

Suggestions

Du même auteur

Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA)

Archive ouverte | Wislez, Marie | CCSD

International audience. IntroductionHIV is an exclusion criterion for most lung cancer (LC) trials, however LC is the most common non-AIDS-defined malignancy in people living with HIV (PLHIV), poorer prognosis than ...

Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA)

Archive ouverte | Wislez, Marie | CCSD

International audience

Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort

Archive ouverte | Brosseau, Solenn | CCSD

CERVOXY CLIN. International audience. Background - Anticancer immune responses are negatively regulated by programmed cell death 1 (PD-1) T-cell membrane protein interaction with its ligand, programmed death ligand ...

Chargement des enrichissements...